Tue, 09th Feb 2021 11:18
NEW DELHI, Feb 9 (Reuters) - Johnson & Johnson is
interested in manufacturing its COVID-19 vaccine in India, a
government official told a news conference on Tuesday.
India also currently has no concern over the efficacy of the
AstraZeneca vaccine that is being used in the country's
massive inoculation campaign, Vinod Kumar Paul said.
(Reporting by Krishna N. Das and Sai Sachin Ravikumar
Editing by Gareth Jones)
(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...
(Correcting company name in headline)
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
Astrazeneca (AZN)